Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mircera 30micrograms/0.3ml inj pre-filled syringes
0901030N0BBAGAG
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | 8 |
|
Mircera 100micrograms/0.3ml inj pre-filled syringes
0901030N0BBACAC
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | 3 |
|
Mircera 50micrograms/0.3ml inj pre-filled syringes
0901030N0BBAAAA
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | 3 |
|
Mircera 120micrograms/0.3ml inj pre-filled syringes
0901030N0BBAHAH
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | 2 |
|
Mircera 75micrograms/0.3ml inj pre-filled syringes
0901030N0BBABAB
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | 1 |
|
Mircera 150micrograms/0.3ml inj pre-filled syringes
0901030N0BBADAD
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Mircera 200micrograms/0.3ml inj pre-filled syringes
0901030N0BBAEAE
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Mircera 250micrograms/0.3ml inj pre-filled syringes
0901030N0BBAFAF
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
|
Mircera 360micrograms/0.6ml inj pre-filled syringes
0901030N0BBAIAI
|
Mircera | Methoxy polyethylene glycol-epoetin beta | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.